| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil serves as a Chief Executive Officer at BBIO. Across recent SEC filings that breaks down to 0 buys and 216 sells. Those positions are worth an estimated $34.3M at current prices.
Historically, Kumar Neil's trades have earned a below-average insider score of 31/100 across 40 rated trades. Over a 12-month horizon, 9.1% of those trades were profitable, with an average 12-month return of -85.0%.
The biggest single holding is BBIO (~$34.3M) as Chief Executive Officer. The recent filings there lean toward selling, a net 4,118,030 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 30,011 | $74.64 | $2,239,902.15 | -11.6% | -4.7% | - | |
| Dec 5, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $73.86 | $5,908,475.89 | -1.7% | -10.0% | - | |
| Nov 20, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 17,313 | $66.07 | $1,143,847.98 | -7.0% | +14.4% | - | |
| Nov 7, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $62.29 | $4,983,111.08 | -9.1% | +3.1% | - | |
| Oct 9, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $54.79 | $4,383,442.21 | -8.7% | +35.6% | +19.3% | |
| Sep 5, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $52.20 | $4,175,835.24 | -8.4% | +40.1% | +40.2% | |
| Aug 20, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 26,156 | $48.82 | $1,276,927.17 | -10.5% | +34.2% | +69.7% | |
| Aug 8, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $45.84 | $3,666,949.26 | -8.0% | +34.7% | +81.4% | |
| Jul 2, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $42.63 | $3,410,450.42 | -7.7% | +21.3% | +80.2% | |
| May 20, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 101,156 | $33.38 | $3,376,741.11 | -2.1% | +45.4% | +102.4% |